The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

VERA FINANCIAL STATEMENTS

Vera Therapeutics Inc — balance sheet, income statement and cash flow trends

VERAVera Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-400 M-200 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit307 K $ · Infinity%Operating Income-415.8 M $ · -Infinity%Pre-tax Income-401.9 M $ · -Infinity%Net Income to Owners-401.9 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $—
Gross Profit307 K $—
Operating Income-415.8 M $—
EBITDA-390 M $—
Net Income to Owners-401.9 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0250 M500 M750 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets533 M
  • Equity407.8 M $77%
  • Current Liabilities48.3 M $9%
  • Long-term Liabilities76.9 M $14%

Key Figures

YoY change
Total Assets533 M $-7.9%
Total Liabilities125.2 M $+13.6%
Total Equity407.8 M $-12.9%
Cash & ST Investments499.2 M $-10.4%
Total Debt75.2 M $-3.0%
Net Debt26.4 M $-7.3%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-300 M-200 M-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-300 M-200 M-100 M0-338.7 M $Operating45.5 M $Investing292.9 M $Financing-245 K $Net Change

Key Figures

YoY change
Operating Cash Flow-338.7 M $—
Capital Expenditures558 K $-56.3%
Free Cash Flow-339.1 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on VERA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.